3) Bristow MR et al ; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 : 2140-2150, 2004
1) Bristow MR et al ; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 : 2140-2150, 2004
4) GISSI-HF Investigators : Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial) : a randomized, double-blind, placebo-controlled trial. Lancet (Epub ahead of print)
2) Brady GHI et al : Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). In : Arrhythmia treatment and therapy : evaluation of clinical trial evidence, ed by Woosley RL, Singh SN, Marcel Dekker, New York, 2000, 323-342
1) Connolly SJ et al ; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators : Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators : the OPTIC Study : a randomized trial. JAM4. 295 : 165-171, 2006
1) Mehta SR et al ; CREATE-ECLA trial group investigators : Effect of glucose-insulinっotassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction : the CREATE-ECLA randomized controlled trial. JAMA 293 : 437-446, 2005
2) van der Horst IC et al ; Zwolle Infarct Study Group : Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction : the glucose-insulin-potassium study : a randomized trial. J Am Coll Cardiol 42 : 784-791, 2003
3) Calabresi L et al : Molecular characterization of native and recombinant apolipoprotein A-I Milano dimer. The introduction of an interchair disulfied bridge remarkably alters the physicochemical properties of apolipoprotein A-I. J Biol Chem 269 : 32168-32174, 1994
3) Braunwald E et al ; American Heart Association. Committee on the Management of Patients With Unstable Angina : ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarctionrsummary article : a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 : 1366-1374, 2002
5) Kastrati A et al : lntracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators : A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350 : 232-238, 2004
1) Cannon CP et al ; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators : Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 : 1495-1504, 2004
1) Lonn E et al ; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators : Homocystein lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 : 1567-1577, 2006
1) Kastrati A et al ; Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators : A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350 : 232-238, 2004
1) Simonton CA et al ; STENT Group : Comparative Clinical Outcomes of Paclitaxel-and Sirolimus-Eluting Stents : result from a arge prospective multicenter registry--STENT Group. J Am Coll Cardiol 50 : 1214-1222, 2007
3) Karjalainen PP et al : Titanium and nitride oxidecoated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol 18 : 462-468, 2006
1) Ruggenenti P et al ; Bergamo Nephrologic Diabetes Conplications Trial (BENEDICT) Investigators : Preventing microalbuminuria in type 2 diabetes. N Engl J Med 351 : 1941-1951, 2004
2) Marre M et al : Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia) --rationale and protocol for the main trial. J Hypertens Suppl 21 : S19-S24, 2003
2) Nakaya H et al : Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 12 : 659-666, 2001
2) CAPRIE Steering Committee : A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 : 1329-1339, 1996
1) Sacco RL et al ; PRoFESS Study Group : Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359 : 1238-1251, 2008
2) Yusuf S et al ; PRoFESS Study Group : Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 359 : 1225-1237, 2008